Evidence map›Paper›PMID 29615094›Full record

ArticleParasites & vectors2018

Heterogeneity in the in vitro susceptibility of Loa loa microfilariae to drugs commonly used in parasitological infections.

Abdel J Njouendou, Fanny F Fombad, Maeghan O'Neill, Denis Zofou, Chuck Nutting, Patrick C Ndongmo, Arnaud J Kengne-Ouafo, Timothy G Geary, Charles D Mackenzie, Samuel Wanji

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Comparative development of human filariaeFrontiers in tropical diseases · 2024
    Article
  2. Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2023
    Article
  3. Review
  4. Review
  5. Advances in preclinical platforms ofFrontiers in tropical diseases · 2021
    Article
  6. Article
  7. Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis.International journal for parasitology. Drugs and drug resistance · 2020
    Article
  8. Article
  9. Article
  10. Dataset onData in brief · 2020
    Article
  11. Mouse models of Loa loa.Nature communications · 2019
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Abdel J NjouendouParasites and Vectors Biology Research Unit (PAVBRU), Department of Microbiology and Parasitology, Faculty of Science, University of Buea, Buea, Cameroon.
Fanny F FombadParasites and Vectors Biology Research Unit (PAVBRU), Department of Microbiology and Parasitology, Faculty of Science, University of Buea, Buea, Cameroon.
Maeghan O'NeillInstitute of Parasitology, McGill University, Ste-Anne-de-Bellevue, QC, H9X 3V9, Canada.
Denis ZofouBiotechnology unit, Department of Biochemistry and Molecular Biology, Faculty of Science, University of Buea, Buea, Cameroon.
Chuck NuttingDepartment of Biological Sciences, Western Michigan University, Kalamazoo, MI, 49008, USA.
Patrick C NdongmoParasites and Vectors Biology Research Unit (PAVBRU), Department of Microbiology and Parasitology, Faculty of Science, University of Buea, Buea, Cameroon.
Arnaud J Kengne-OuafoParasites and Vectors Biology Research Unit (PAVBRU), Department of Microbiology and Parasitology, Faculty of Science, University of Buea, Buea, Cameroon.
Timothy G GearyInstitute of Parasitology, McGill University, Ste-Anne-de-Bellevue, QC, H9X 3V9, Canada.
Charles D MackenzieDepartment of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI, 48824, USA.
Samuel WanjiParasites and Vectors Biology Research Unit (PAVBRU), Department of Microbiology and Parasitology, Faculty of Science, University of Buea, Buea, Cameroon. swanji@yahoo.fr.ORCID 0000-0003-0022-8366
University of Buea · CMMcGill University · CALiverpool School of Tropical Medicine · GBWestern Michigan University · US

Funding

DNDi Partial fianncial support through drugs
6 · The paper itself

Abstract

backgroundCo-infection with loiasis remains a potential problem in control programs targeting filarial infections. The effects of many anti-parasitic drugs often administered to Loa loa infected people are not well documented. This study compared the in vitro activity of several of these drugs on the viability of L. loa microfilariae (mf).

methodsHuman strain L. loa mf were isolated from baboon blood using iso-osmotic Percoll gradient, and cultured in RPMI 1640/10% FBS with antimalarial drugs (mefloquine, amodiaquine, artesunate, chloroquine and quinine), anthelmintics (ivermectin, praziquantel, flubendazole and its reduced and hydrolyzed metabolites), two potential trypanocidal agents (fexinidazole and Scynexis-7158) and the anticancer drug imatinib. The drug concentrations used varied between 0.156 μg/ml and 10 μg/ml. Mf motility (CR

resultsMf in control cultures showed only a slight reduction in motility after 5 days of culture. Active inhibition of Loa loa motility was seen with mefloquine and amodiaquine (CR

conclusionsThe considerable action of the anti-malarial drugs mefloquine and amodiaquine on Loa mf in vitro highlights the possibility of repurposing the existing anti-infectious agents for the development of drugs against loiasis. The heterogeneity in the activity of anti-parasitic agents on Loa loa mf supports the need for further investigation using animal models of loiasis.

Indexed as

AnimalsAntineoplastic AgentsAntiparasitic AgentsLoaMovementParasitic Sensitivity TestsSurvival AnalysisAntineoplastic AgentsAntiparasitic AgentsAnthelminticsAntimalarialImatinibLoa loa microfilariaeTrypanocides

Identifiers

PMID29615094
PMCPMC5883330
OpenAlexW2803469636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.